SCHEMBL9806501

SCHEMBL9806501

CCOC(=O)C(=O)Cc1cccc([N+](=O)[O-])c1Cl

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CACNA1C Q13936 2/20 0.44
CACNA1F O60840 1/20 0.44
CACNA1D Q01668 1/20 0.44
CACNA1S Q13698 1/20 0.44
RAB9A P51151 3/20 0.43
GPR35 Q9HC97 1/20 0.43
CES2 O00748 1/20 0.42
ACHE P22303 1/20 0.42
CES1 P23141 1/20 0.42
L3MBTL1 Q9Y468 1/20 0.42
MEN1 O00255 3/20 0.41
KMT2A Q03164 3/20 0.41
SMN1; SMN2 Q16637 3/20 0.41
NPC1 O15118 2/20 0.41
CYP3A4 P08684 1/20 0.41
CYP2D6 P10635 1/20 0.41
CYP2C19 P33261 1/20 0.41
KDM4E B2RXH2 2/20 0.41
CTDSP1 Q9GZU7 1/20 0.41
ALDH1A1 P00352 3/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7634832 0.86 TDP1 (0.50) CACNA1CRAB9ACES2ACHECES1
SCHEMBL2606755 0.86 KMT2A (0.55) RAB9ACES2ACHECES1L3MBTL1
SCHEMBL31016519 0.86 KMT2A (0.55) RAB9ACES2ACHECES1L3MBTL1
Alcohol SCHEMBL28003927 0.83 MEN1 (0.52) RAB9ACES2ACHECES1L3MBTL1
SCHEMBL1716245 0.81 CES2 (0.46) CACNA1CRAB9AGPR35CES2ACHE
SCHEMBL16585208 0.81 LMNA (0.44) CACNA1CRAB9ACES2ACHECES1
SCHEMBL31016515 0.81 LMNA (0.44) CACNA1CRAB9ACES2ACHECES1
SCHEMBL1500911 0.78 MEN1 (0.46) RAB9AL3MBTL1MEN1KMT2ANPC1
SCHEMBL3962914 0.78 CYP1A2 (0.51) RAB9AGPR35L3MBTL1SMN1; SMN2NPC1
SCHEMBL9780752 0.78 NPC1 (0.48) RAB9AGPR35L3MBTL1MEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5017604-A Antiinflammatory WARNER-LAMBERT COMPANY (US) 1991-05-21 US disclosed